Alterity Therapeutics ATHE
NASDAQ ATHE
$4.67 +0.22 (+4.94%)
As of: Aug 21, 2026 · 3:59 PM EDT

Alterity Therapeutics (ATHE) Selling, General & Administrative (2014 - 2025)

Alterity Therapeutics (ATHE) Selling, General & Administrative (2014 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 582.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 662.10 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.13 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 216.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 593.21 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 347.92 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -196.26 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 247.47 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 161.89 Mn
10 Alterity Therapeutics 48.56 Mn 16.26 Mn - -3.50 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -3.50 Mn
Dec 31, 2024 -2.13 Mn
Dec 31, 2023 -2.68 Mn
Dec 31, 2022 -2.20 Mn
Dec 31, 2021 -2.69 Mn
Dec 31, 2019 244,990.86
Dec 31, 2018 -1.46 Mn
Dec 31, 2017 -1.52 Mn
Dec 31, 2016 1.52 Mn
Dec 31, 2015 -1.74 Mn
Dec 31, 2014 356,759.22